title: Association of focal nodular hyperplasia and hepatic hemangioma.
abstract: The association between hepatic hemangioma and focal nodular hyperplasia has been occasionally reported. To evaluate the reality of this association, the prevalence of hemangioma was studied in 26 patients with focal nodular hyperplasia by comparison with 27 patients with hepatocellular adenoma. All of these patients underwent surgery, which provided the histologic confirmation of the type of tumor. The presence of hemangioma was assessed by preoperative ultrasonography, dynamic computed tomography, and pathological examination of resected liver specimens. No hemangioma was found in patients with hepatocellular adenoma, but 6 of the 26 patients with focal nodular hyperplasia (23%) had one or two associated hemangiomas that varied in size from 1.5 to 4 cm. All 6 patients having focal nodular hyperplasia and hemangioma were women who had previously used oral contraceptives. None of the patients who had not used oral contraceptives had this association. Moreover, oral contraceptives were taken for a significantly longer period by the women with focal nodular hyperplasia and hemangioma than by those without this association. It is concluded that (a) the association of hemangioma with focal nodular hyperplasia is frequent (23%) and not fortuitous, and (b) prolonged administration of oral contraceptives may facilitate the recognition of this association, possibly by affecting the growth of these tumors.
authors.affiliation: Department of Radiology, Unité INSERM Unit 99, Créil, France.
authors.forename: D
authors.initials: D
authors.lastname: Mathieu
authors.forename: E S
authors.initials: ES
authors.lastname: Zafrani
authors.forename: M C
authors.initials: MC
authors.lastname: Anglade
authors.forename: D
authors.initials: D
authors.lastname: Dhumeaux
mesh_terms: D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000473:pathology*; D003276:Contraceptives, Oral / Q000009:adverse effects; D005260:Female; D006391:Hemangioma / Q000139:chemically induced / Q000150:complications* / Q000473:pathology; D006801:Humans; D006965:Hyperplasia / Q000139:chemically induced / Q000150:complications; D008099:Liver / Q000473:pathology*; D008113:Liver Neoplasms / Q000139:chemically induced / Q000150:complications* / Q000473:pathology; D008297:Male; D008875:Middle Aged
chemical_list: D003276:Contraceptives, Oral